Early detection of cerebral arterial occlusion on magnetic resonance angiography: Predictive value of the baseline NIHSS score and impact on neurological outcome

Cerebrovascular Diseases

Volumn 13, Issue 4, 2002, Pages 225-229

  Derex, Laurent ^a   Nighoghossian, N ^a,b   Hermier, M ^a,b   Adeleine, P ^b   Froment, J C ^a,b   Trouillas, P ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

Ischemic stroke; Magnetic resonance angiography; NIHSS score

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PREDICTION; PRIORITY JOURNAL; SCREENING TEST; STROKE; BRAIN ARTERY; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; DRUG EFFECT; EVALUATION; FOLLOW UP; HOSPITALIZATION; MIDDLE AGED; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RADIOGRAPHY; VASCULAR PATENCY;

ADULT; AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; CEREBRAL ARTERIES; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR PATENCY; HUMANS; MIDDLE AGED;

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0036000301     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057847     Document Type: Article

References (16)

1. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke
2. Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra
3. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke. Determination of etiological, topographic and radiological outcomes factors
4. Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial. TOAST: Trial of Org 10 172 in Acute Stroke Treatment
5. Progression in acute stroke. Value of the initial NIH Stroke Scale score on patient stratification in future trials
6. Baseline NIH Stroke scale strongly predicts outcome after stroke: A report of the Trial of Org 10 172 in Acute Stroke Treatment (TOAST)
7. Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke
8. Effect of blood pressure and diabetes on stroke in progression
9. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia
10. Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI
11. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI
12. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI
13. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial
14. Tissue plasminogen activator for acute ischemic stroke
15. Outcome of stroke patients without angiographically revealed arterial occlusion within four hours of symptom onset
16. Diffusion and perfusion magnetic resonance imaging for the evaluation of acute stroke: Potential use in guiding thrombolytic therapy